Human Stem Cells in Disease Modelling and Treatment
This special issue belongs to the section "Biomedical Engineering and Materials".
Special Issue Information
Dear Colleagues,
Over the last few decades, human stem cells have gained significant attention in biomedical research due to their unprecedented applications, both in terms of disease modelling and therapy. In addition, although rodents have been widely used as a model, they often fail to mirror the pathophysiology of human diseases due to species-specific differences.
This Special Issue of Biomedicines aims to highlight the most recent advances in the field of human stem cell modelling, translation, and clinical application. Topics of interest include, but are not limited to, the following:
- Novel applications of human stem cells to study disease mechanisms;
- The use of human stem cells in regenerative medicine;
- Obstacles related to the cGMP compliance of human stem cells in regenerative medicine applications;
- Other limitations in the clinical translation of human stem cells for regenerative medicine.
Dr. Sofia M. Calado
Dr. Álvaro Plaza Reyes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- induced pluripotent stem cells (iPSCs)
- embryonic stem cells (ESCs)
- disease models
- cell therapies
- cell therapy medicinal products (CTMPs)
- regenerative medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Biomedicines - ISSN 2227-9059